We are live on ! Find out more
CALC icon

CalciMedica

28 hedge funds and large institutions have $20.7M invested in CalciMedica in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

8% more funds holding

Funds holding: 2628 (+2)

2% more call options, than puts

Call options by funds: $537K | Put options by funds: $527K

44% less capital invested

Capital invested by funds: $37M → $20.7M (-$16.4M)

Holders
28
Holders Change
+2
Holders Change %
+7.69%
% of All Funds
0.43%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
6
Reduced
3
Closed
6
Calls
$537K
Puts
$527K
Net Calls
+$10K
Net Calls Change
+$382K

CALC Hedge Fund Activity: Q4 2021 in Review

28 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q4 2021, worth a combined $20.7M — down 44% from $37M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new CALC positions and 6 closed out — a net gain of 2 holders — while 6 added to existing stakes and 3 trimmed.

The largest buyer was Two Sigma Investments, opening a new position worth an estimated $259K. The largest seller was JP Morgan Chase, exiting entirely with an estimated $358K sold.

  • 28 institutional investors held CalciMedica (CALC) as of Q4 2021, up from 26 in Q3 2021.
  • Funds reported $20.7M of CalciMedica stock for Q4 2021, down 44% quarter-over-quarter.
  • 8 funds opened new CalciMedica positions in Q4 2021 and 6 closed out, a net change of +2 holders.
  • The largest CalciMedica buyer in Q4 2021 was Two Sigma Investments, an estimated $259K added.
  • The largest CalciMedica seller in Q4 2021 was JP Morgan Chase, an estimated $358K sold.

Based on aggregated 13F filings for Q4 2021.